F076 Cutaneous Lymphoma or Not? Clinicopathologic Challenges and Practical Pearls
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
This session will present case-based diagnostic challenges including a wide range of cutaneous T- and B-cell lymphomas, from uncommon clinical variants of mycosis fungoides to rarer, more aggressive or life-threatening lymphomas. The goal is to familiarize audience members with clinical, histopathologic and molecular tools for diagnosis of cutaneous lymphomas, focusing on clues to distinguish lymphomas from inflammatory mimics. Implications for clinical management will also be discussed.
LEARNING OBJECTIVES
Recognize uncommon presentations of mycosis fungoides and other cutaneous lymphomas based on clinical and histopathologic findings.
Distinguish between cutaneous lymphoma and inflammatory mimics based on clinical and histopathologic findings, immunohistochemical studies, and molecular tests.
Describe how accurately differentiating between cutaneous lymphomas and inflammatory mimics may impact the approach to clinical management.
SCHEDULE
1:00 PM
Introduction and Case Presentations
Jennifer Yu Wang, MD, FAAD
1:20 PM
Case Presentations
Julia Dai, MD, FAAD
1:40 PM
Case Presentations
Roberto Novoa, MD, FAAD
2:00 PM
Case Presentations
Jina Chung, MD, FAAD
2:20 PM
Case Presentations
Joan Guitart, MD, FAAD
2:40 PM
Q&A
SPEAKERS
Jina Chung, MD, FAAD
Julia Dai, MD, FAAD
Joan Guitart, MD, FAAD
Roberto Novoa, MD, FAAD
Jennifer Yu Wang, MD, FAAD
SPEAKER DISCLOSURES
Jina Chung, MD, FAAD
No financial relationships exist with ineligible companies.
Julia Dai, MD, FAAD
No financial relationships exist with ineligible companies.
Joan Guitart, MD, FAAD
Castle Biosciences – Consultant (1099 relationship)(Fees); Kyowa Hakko Kirin Pharma, Inc. – Consultant(Honoraria);
Roberto Novoa, MD, FAAD
Enspectra Health – Consultant(Stock Options); Iovance Biotherapeutics – Stockholder Public Company(Stock); L'Oreal USA Inc. – Investigator(Grants/Research Funding); Melanoma Research Alliance – Investigator(Grants/Research Funding); Moderna Therapeutics – Stockholder Public Company(Stock); Sanctum LLC – Advisory Board(Stock); Skin Analytics – Investigator(Grants/Research Funding);
Jennifer Yu Wang, MD, FAAD
Enspectra Health – Consultant (1099 relationship)(Fees);